Navigation Links
BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties
Date:12/23/2009

EXTON, Pa., Dec. 23 /PRNewswire/ -- BioTrends Research Group, Inc. published a syndicated research report, "TreatmentTrends®: Anemia in the United States," based on primary research conducted with approximately 400 physicians in clinical practice. The report evaluates patient types, referral patterns and treatment approaches as reported by Hematologists, Oncologists, Nephrologists, Gastroenterologists, OB-GYNs, Rheumatologists, Cardiologists and Primary Care Physicians.

The independent study was conducted to better understand the array of different types (and underlying causes) of anemia and how they vary among different specialists. The report examines which patient types are most commonly seen by each specialist, which specialists are likely to treat the anemia themselves (as opposed to referring out), what factors influence the decision to treat the anemia, the prevalence of iron treatment, ESA treatment and use of blood transfusions. The use and frequency of laboratory parameters as assessment tools is also compared across the specialties providing insight on the approach to diagnosis and treatment.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or www.bio-trends.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.


    Contact:     Jennifer Robinson    (610) 363-3872

SOURCE BioTrends Research Group, Inc.


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
2. Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
3. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
8. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
9. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
10. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
11. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness Month with a ... tell their personal story and encourage those at risk to get tested and begin the ... ... ... Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... YORK , May 3, 2016 ... (MRI) Market Size, Share, Development, Growth and Demand Forecast ... Open), by Field Strength (High Field, Very High Field, ... Application (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Breast, ... the global magnetic resonance imaging (MRI) market was valued ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... California ... a web application that helps people assess their risk of developing Alzheimer’s disease. ... will provide users a “Risk Reduction Score™” that summarizes how their lifestyle choices ...
(Date:5/3/2016)... ... May 03, 2016 , ... Horizon ... has been honored as one of the nation’s most accomplished business technology innovators ... Horizon received the recognition for technology achievements that have enabled the delivery of ...
(Date:5/3/2016)... Texas (PRWEB) , ... May 03, 2016 , ... Excessive ... the signs of pet anxiety. "Pet owners often think anxiety only manifests itself ... stress signals in other ways, and there’s things that be done about it,” says ...
(Date:5/3/2016)... ... ... personal injury law firm Monge & Associates is honoring Moms in the time ... for their Mother or any other mother figure. , According to law firm founder, Scott ... on to say, “we are choosing to do this by giving free roses to those ...
(Date:5/3/2016)... ... May 03, 2016 , ... Intrigma, the leading ... Legacy Health is expanding its use of Intrigma’s cloud-based physician scheduling solution, Efficient ... proof of concept. The Portland, Oregon based health system conducted a one-year pilot ...
Breaking Medicine News(10 mins):